• Home
  • Brochure
  • Scientific Committee
  • Speakers
  • Agenda
  • Venue
  • Contact
  • Submit Abstract
  • Register

SCIENTIFIC COMMITTEE

    view profile

    Dr. Ted Rothstein

    George Washington University, USA
    view profile

    Dr. Bram Palache

    Flupal Consultancy, Netherlands
    view profile

    Dr. Airi Poder

    Clinical Research OU, Estonia
    view profile

    Ping Wu

    University of Texas Medical Branch, USA
    view profile

    Dr. Sam Pallerla

    Director at Vaxcyte, USA

Dr. Ted Rothstein

George Washington University

USA

Neuroanatomic changes associated with 55 consecutive long-term post COVID-19 patients with cognitive deficits

Dr. Bram Palache

Flupal Consultancy

Netherlands

Disparities in Seasonal Influenza Vaccination in Europe

Dr. Airi Poder

Clinical Research OU

Estonia

Recruitment Strategies for Vaccine Trials in Areas of Low Population Density

Ping Wu

University of Texas Medical Branch

USA

Antiviral and immunomodulatory effects of ouabain against congenital Zika syndrome model

Dr. Sam Pallerla

Director at Vaxcyte

USA

Sam Pallerla, Ph.D., is Director of Global Drug Substance Commercialization at Vaxcyte, where he leads conjugate vaccine manufacturing and commercialization programs. He has more than 25 years of experience in vaccine and biologics process development, CMC strategy, technology transfer, clinical manufacturing, and commercial product development.
Prior to joining Vaxcyte, Dr. Pallerla held leadership roles at the International AIDS Vaccine Initiative.

Contact Information

+1-408-465-0048
ryan_cooper@vaccine-congress.org
+1-408-352-1010

Locate US

5201 Great America Pkwy #320, Santa Clara, CA 95054, United States"

Keep me Updated..!


Copyrights © 2020-21 Innovinc International, All Rights Reserved